Home Promus PREMIER(TM) Everolimus-Eluting Platinum Chromium Stent System Receives CE Mark Approval
 

Keywords :   


Promus PREMIER(TM) Everolimus-Eluting Platinum Chromium Stent System Receives CE Mark Approval

2013-02-12 06:00:00| Industrial Newsroom - All News for Today

The Next Advance in Durable Polymer Stent Technology from Boston Scientific is Now Available in Europe and Other Select Geographies NATICK, Mass. - Boston Scientific Corporation (NYSE: BSX) has received CE Mark approval for the Promus PREMIER(TM) Everolimus-Eluting Platinum Chromium Coronary Stent System, the company's next-generation durable polymer drug-eluting stent (DES) technology, and is starting its European market launch. The Promus PREMIER Stent System is designed to provide ...This story is related to the following:Stents

Tags: system mark approval receives

Category:Industrial Goods and Services

Latest from this category

All news

19.11POWTEX2024 The 25th International Powder Technology Exhibition Tokyo
Industrial Goods and Services »
24.11MSX2
24.11CITY 1-13
24.11 Loveyoursself Soul DVD
24.11B787-8 1/400
24.11GIANT CONTEND SL1105
24.11HappySanrio characters Halloween
24.11
24.11emmi
More »